DRI-ecstasy plus mdma/MDA reagent

Ended Awarded

Contract number
N6854620F6066
Awardee
Awarding agency
Obligated
$6,020

Award facts

Contract value 100% obligated
$6,019.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fremont, CA 94538, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded a $6,019.50 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA reagent. Microgenics, a division of Thermo Electron Corporation, will deliver the requested products to the place of performance in Fremont, California by the completion date of September 22, 2020. The award was made on September 11, 2020 with no set-aside designation specified. The reagent is likely being procured to support drug testing and analysis programs conducted by the Bureau of Medicine and Surgery for the Department of the Navy.

Quick answers

Who was awarded contract N6854620F6066?

N6854620F6066 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on September 11, 2020.

How much is contract N6854620F6066 worth?

The government has obligated $6,020 on N6854620F6066.

Is contract N6854620F6066 an order under another contract?

Yes. N6854620F6066 is a delivery order under N6264519D5003, an indefinite delivery contract.

Was contract N6854620F6066 competed?

The extent of competition for N6854620F6066 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award